Geneva University Hospital

Geneva 1211

1 studies enrolling now · 9 studies all time

What they study most

Acquired Immunodeficiency Syndrome, Aneurysmal Subarachnoid Hemorrhage, Coronary Artery Disease, HIV Infections, HIV-1 Infection, Ischemic Heart Disease, Medullary Thyroid Cancer, Stroke, Suspected Upper Extremity Deep Vein Thrombosis, Transient Ischemic Attack

Studies at this site

• Distal Evaluation of Functional Performance with Intravascular Sensors to Assess the Narrowing Effect: Guided Physiologic Stenting — Enrolling by invitation
• Predictive Factors for Medullary Thyroid Cancer Aggressiveness — Completed
• Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Surgical Clipping — Completed
• Study to Evaluate Switching From a Regimen Consisting of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate (EFV/FTC/TDF) Fixed Dose Combination (FDC) to Emtricitabine/Rilpivirine/Tenofovir Alafenamide (FTC/RPV/TAF) FDC in Virologically-Suppressed, HIV-1 Infected Adults — Completed
• Switch Study to Evaluate the Safety and Efficacy of Emtricitabine/Rilpivirine/Tenofovir Alafenamide (FTC/RPV/TAF) Fixed Dose Combination (FDC) in HIV-1 Positive Adults Who Are Virologically Suppressed on Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate (FTC/RPV/TDF) — Completed
• Clazosentan in Aneurysmal Subarachnoid Hemorrhage — Stopped early
• International PFO Consortium — Status unconfirmed
• Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor Plus Emtricitabine/Tenofovir Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients — Completed
• Diagnostic Algorithm in Suspected Upper Extremity Deep Vein Thrombosis — Completed